Vaccine

Role of Social Media in Science-in-Society issues

Tuesday, April 10, 2018 - 17:32

Social media and ASSET

Nowadays, social media is an increasingly common and integral part of all people's lives. In ASSET theory and practice about social media have been explored extensively over the four years of work (2014-2017). It has been done by studying to what extent epidemic or pandemic preparedness and response are covered by contents shared on the main social network platforms. Specific studies have been developed such as analysing the social accounts and profiles of relevant pharmaceutical companies. 

Target: 
Government and Public Health, Healthcare Professionals
Topic: 
Social Media, Stakeholders, Vaccination
Tags: 
Social media, Vaccine

Questions and answers: Health mediation in Bulgaria

Dilyana Dilkova – Member of the Managing Board, National Network of Health Mediators; d.dilkova@gmail.com

Country: 
Bulgaria
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Human Rights, Local Activities, Vaccination
Tags: 
best practice, Vaccine, communication, Roma

Questions and answers: French Citizen Consultation on Vaccination

Professor Alain Fischer (info@concertation-vaccination.fr), doctor, professor of paediatric immunology, director of the Institute Imagine, holder of the chair of Experimental Medicine of the Collège de France and President of the Steering Committee for the Citizen Consultation initiative.

Country: 
France
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Citizens' Mobilization, Local Activities, Vaccination
Tags: 
Vaccine, risk communication, science-in-society

Questions and answers: Immuniser Lyon

Dr Anne Sophie Ronnaux-Baron cdhs@cdhs.fr

Country: 
France
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Stakeholders, Vaccination
Tags: 
Vaccine, best practice

Pregnancy and influenza

Monday, November 13, 2017 - 12:39

Women who are pregnant are more likely to have severe disease and hospitalisation with either seasonal or pandemic influenza, compared to the general population or compared to non-pregnant women of the same age group. During pandemics, the mortality rate for pregnant women is higher than non-pregnant women. However, this is not the case with seasonal influenza unless the strain is particularly severe (WHO 2010).

Target: 
Citizens, Healthcare Professionals
Topic: 
Epidemiology, Gender, Stakeholders, Vaccination
Tags: 
gender issues, gender, influenza, flu, Vaccine

Immunization in healthcare workers

Tuesday, October 24, 2017 - 08:39

The report of the WHO SAGE Vaccine Hesitancy Working Group defined vaccine hesitancy as “a behaviour, influenced by a number of factors including issues of confidence (e.g. low level of trust in vaccine or provider), complacency (e.g. negative perceptions of the need for, or value of, vaccines], and convenience (e.g. lack of easy access)”.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Policy, Prevention, Stakeholders, Vaccination
Tags: 
Dataviz, Vaccine, Health care workers

Best practice guidance – How to respond to vocal vaccine deniers in public

WHO. 2016. Best practice guidance – How to respond to vocal vaccine deniers in public.

Target: 
Government and Public Health, Healthcare Professionals
Topic: 
Media, Stakeholders, Vaccination
Tags: 
WHO, guidance, Vaccine, Health communication

Directive 2000/54/EC of the European Parliament and of the Council

Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work

Target: 
Government and Public Health, Healthcare Professionals
Topic: 
Prevention, Stakeholders, Vaccination
Tags: 
European Parliament, biological agents, HCWs, protection, Vaccine

The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations

Karafillakis E, Larson HJ; ADVANCE consortium. Vaccine. 2017 Jul 28.

Objectives:
The success of vaccination strategies depends in part on population perceptions of benefits and risks of vaccines and related confidence in vaccination. Better knowledge of public concerns about vaccines and what is driving them is needed to inform vaccination strategies and communications. This literature reviewer examined studies on vaccine and vaccination risk perceptions and concerns across European populations.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Vaccination
Tags: 
Vaccine, Vaccine hesitancy, ​risk perception, Health communication, vaccination campaigns

Gender issues in chronic diseases and influenza vaccines

Monday, August 7, 2017 - 15:05

People with already existing conditions, such as cardiovascular diseases, diabetes, and pulmonary/respiratory disease, are at greater risk from influenza (Logue et al., 2011). Women are more likely to have diabetes in their lifetime than men, and studies in the US show that women, particularly those in lower socioeconomic groups, receive less adequate diabetes care than men from the same socioeconomic group (WHO, 2010).

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Gender, Policy, Prevention, Stakeholders, Vaccination
Tags: 
gender issues, influenza, Vaccine, chronic diseases

Pages

Subscribe to Vaccine

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence